Quotient Sciences’ Translational Pharmaceutics® platform innovates the way you design and implement your drug development program. It offers you integrated formulation development, real-time adaptive GMP manufacturing and clinical research capabilities proven to reduce drug development costs and shorten timelines.
Translational Pharmaceutics transforms the traditional approach of outsourcing development work to separate contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) – simplifying and streamlining your outsourcing and program management.
The development of acceptable, palatable pediatric formulations is a key feature within the industry today, driven by patient needs and regulatory requirements.
Quotient Sciences has extensive knowledge and capabilities that enable us to provide you with a unique integrated development solution.